Selling and Marketing Expense in USD of P3 Health Partners Inc. from 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
Summary
P3 Health Partners Inc. quarterly/annual Selling and Marketing Expense history and growth rate from 2019 to Q3 2025.
  • P3 Health Partners Inc. Selling and Marketing Expense for the quarter ending September 30, 2025 was $251K, a 87.3% increase year-over-year.
  • P3 Health Partners Inc. Selling and Marketing Expense for the twelve months ending September 30, 2025 was $1.04M, a 34.4% decline year-over-year.
  • P3 Health Partners Inc. annual Selling and Marketing Expense for 2024 was $1.33M, a 58.8% decline from 2023.
  • P3 Health Partners Inc. annual Selling and Marketing Expense for 2023 was $3.23M, a 36.6% decline from 2022.
  • P3 Health Partners Inc. annual Selling and Marketing Expense for 2022 was $5.1M, a 180% increase from 2021.
Selling and Marketing Expense, Trailing 12 Months (USD)
Selling and Marketing Expense, Quarterly (USD)
Selling and Marketing Expense, YoY Quarterly Growth (%)
Selling and Marketing Expense, Annual (USD)
Selling and Marketing Expense, YoY Annual Growth (%)

P3 Health Partners Inc. Quarterly Selling and Marketing Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $1.04M $251K +$117K +87.3% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-14
Q2 2025 $927K $151K -$263K -63.5% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-14
Q1 2025 $1.19M $181K -$141K -43.8% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-15
Q4 2024 $1.33M $461K -$260K -36.1% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-28
Q3 2024 $1.59M $134K -$520K -79.5% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-14
Q2 2024 $2.11M $414K -$443K -51.7% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-14
Q1 2024 $2.55M $322K -$679K -67.8% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-15
Q4 2023 $3.23M $721K -$984K -57.7% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-28
Q3 2023 $4.22M $654K -$464K -41.5% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $4.68M $857K -$551K -39.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $5.23M $1M +$136K +15.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 $5.1M $1.71M +$1.34M +368% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 $3.76M $1.12M +$627K +128% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $3.13M $1.41M +$1.05M +295% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 $2.08M $865K +$595K +220% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $364K Dec 3, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 $491K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $357K Apr 1, 2021 Jun 30, 2021 10-Q 2022-10-21
Q1 2021 $270K Jan 1, 2021 Mar 31, 2021 10-Q 2022-10-21

P3 Health Partners Inc. Annual Selling and Marketing Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $1.33M -$1.9M -58.8% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-28
2023 $3.23M -$1.86M -36.6% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-28
2022 $5.1M +$3.28M +180% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 $1.82M +$315K +21% Jan 1, 2021 Dec 2, 2021 10-K 2023-03-31
2020 $1.5M +$701K +87.4% Jan 1, 2020 Dec 31, 2020 10-K 2022-10-21
2019 $802K Jan 1, 2019 Dec 31, 2019 10-K 2022-10-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.